Cancer and Clinical Oncology (CCO) is a peer-reviewed, open access journal, published by Canadian Center of Science and Education. The journal publishes original research, reviews, case analysis and other material on all aspects of clinical oncology research, including the pathophysiology, prevention, diagnosis and treatment of malignant disease.
Authors are encouraged to submit complete unpublished and original works, which are not under review in any other journals. The journal welcomes submissions concerning molecular and cellular biology, genetics, clinical trials, radiology, surgery, and palliative care.
The journal is published in both printed and online versions. The online version is free to access and download.
2016 Q2: Articles Received: 10; Accepted: 8; Rejected: 5; Published: 4; Retracted: 0
2016 Q1: Articles Received: 18; Accepted: 9; Rejected: 7; Published: 5; Retracted: 0
2015: Articles Received: 23; Accepted: 14; Rejected: 4; Published: 13; Retracted: 0
2014: Articles Received: 32; Accepted: 21; Rejected: 12; Published: 14; Retracted: 02013: Articles Received: 36; Accepted: 19; Rejected: 15; Published: 19; Retracted: 0
What is e-Version FirstTM
e-Version First is a feature offered through our journal platform. It allows PDF version of manuscripts that have been peer reviewed and accepted, to be hosted online prior to their inclusion in a final printed journal. Readers can freely access or cite the article.
We aim to publish accepted manuscripts in e-Version First within a week after the final draft completed.
Each paper published in Cancer and Clinical Oncology is assigned a DOI®number, which appears beneath the author's affiliation in the published paper. Click HERE to know what is DOI (Digital Object Identifier)? Click HERE to retrieve Digital Object Identifiers (DOIs) for journal articles, books, and chapters.
Paper Selection and Publication Process
a). Upon receipt of paper submission, the Editor sends an E-mail of confirmation to the corresponding author within 1-3 working days. If you fail to receive this confirmation, your submission/e-mail may be missed. Please contact the Editor in time for that.
b). Peer review. We use double-blind system for peer-review; both reviewers and authors’ identities remain anonymous. The paper will be peer-reviewed by three experts; two reviewers from outside and one editor from the journal typically involve in reviewing a submission. The review process may take 2-3 weeks.
c). Notification of the result of review by E-mail.
d). The authors revise paper and pay publication fee (300USD).
e). After publication, the corresponding author will receive two copies of printed journals, free of charge.
f). E-journal in PDF is available on the journal’s webpage, free of charge for download.
The publisher and journal have a policy of “Zero Tolerance on the Plagiarism”. We check the plagiarism issue through two methods: reviewer check and plagiarism prevention tool (ithenticate.com).
All submissions will be checked by iThenticate before being sent to reviewers.
PKP Open Archives Harvester
Standard Periodical Directory
We are recruiting reviewers for the journal. If you are interested in reviewing submissions, we welcome you to join us. Please find further details at http://recruitment.ccsenet.orgIf you have any questions, please contact the editorial assistant at email@example.com
CCO, Vol. 5, No. 2, November 2016: Call for Papers
Cancer and Clinical Oncology (CCO) is calling for submission of papers for the Vol. 5, No. 2, November 2016 issue. You are cordially invited to submit manuscripts to CCO. If you are interested in submitting a manuscript to CCO, please view the journal’s profile and submit your manuscripts online.
If you have any questions, please feel free to contact us.
Vol 5, No 2 (2016)
Table of Contents
Cardiovascular Toxicity of Bevacizumab in Long-term Survival of Recurrent Ovarian Cancer: A Case Report
Kenneth O. Simbiri, Hem C. Jha, Giacomina Giacomina Massaro-Giordano, Erle S. Robertson
Non-Association of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms with Homocysteine Levels, Venous or Arterial Thromboses in 1,141 North-Central Appalachian Patients
Farhad Khimani, Peter Perrotta, Gerry Hobbs, Thomas Hogan
Colorectal Cancer Survival Disparities among Puerto Rican Hispanics: A Comparison to Racial/Ethnic Groups in the United States
Maria Gonzalez-Pons, Mariela Torres, Javier Perez, Anneliese Velez, Jean Pierre Betancourt, Lorena Marcano, Marievelisse Soto-Salgado, Marcia Cruz-Correa